Optimal surgical cytoreduction in patients with Stage III and Stage IV endometrial carcinoma: A study of morbidity and survival

Gynecologic Oncology

Volumn 93, Issue 3, 2004, Pages 653-658

  Lambrou, Nicholas C ^a   Gómez Marín, Orlando ^a   Mirhashemi, Ramin ^a   Beach, Heather ^a   Salom, Emery ^a   Almeida Parra, Zoyla ^a   Peñalver, Manuel ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Cytoreduction; Endometrial carcinoma; Primary surgery

Indexed keywords

ABDOMINAL HYSTERECTOMY; ADULT; AGED; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLEAR CELL CARCINOMA; CONFERENCE PAPER; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INTESTINE RESECTION; LENGTH OF STAY; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MORBIDITY; OMENTECTOMY; PAPILLARY CARCINOMA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; SALPINGOOOPHORECTOMY; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, ENDOMETRIOID; CHEMOTHERAPY, ADJUVANT; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; MORBIDITY; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE;

EID: 2942670574     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.03.015     Document Type: Conference Paper

References (10)

1. Pecorelli S., Creasman W., Pettersson F., Benedet J.L., Shaperd J.H. FIGO Annual Report on the Results of Treatment in Gynecologic Cancer. J. Epidemiol. Biostat. vol. 3:1998;35-62
2. Ayhan A., Taskiran C., Celik C., Yuce K., Kucukali T. The influence of cytoreductive surgery on survival and morbidity in stage IVB endometrial cancer. Int. J. Gynecol. Cancer. 12:2002;448-453
3. Bristow R.E., Zerbe M.J., Rosenshein N.B., Grumbine F.C., Montz F.J. Stage IV endometrial carcinoma. The role of cytoreductive surgery and determinants of survival. Gynecol. Oncol. 78:2000;85-91
4. Chi D.S., Welshinger M., Venkatraman E.S., Barakat R.R. The role of surgical cytoreduction in stage IV endometrial carcinoma. Gynecol. Oncol. 67:1997;56-60
5. Goff B.A., Goodman A., Muntz H.G., Fuller A.F., Nikrui N., Rice L.W. Surgical stage IV endometrial carcinoma: a study of 47 cases. Gynecol. Oncol. 52:1944;237-240
6. Randall M.E., Spirtos N.M., Dvoretsky Whole abdominal radiotherapy versus combination chemotherapy with doxorubicin and cisplatin in advanced endometrial carcinoma (phase III): Gynecologic Oncology Group Study No. 122. Monogr. Natl. Cancer Inst. 19:1995;13-15
7. Kaplan E.L., Meier P. Non-parametric estimation for incomplete observations. J. Am. Stat. Assoc. 53:1958;457-481
8. Mantel N., Haensel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 22:1959;719-748
9. Greer B.E., Hamberger A.D. Treatment of intraperitoneal metastatic adenocarcinoma of the endometrium by the whole-abdomen moving-stip technique and pelvic boost irradiation. Gynecol. Oncol. 16:1983;365-373
10. Martinez A., Podratz K., Shray M., Malkasian G. Results of whole abdominopelvic irradiation with nodal boost for patients with endometrial cancer at high risk of failure in the peritoneal cavity: a prospective clinical trial at the Mayo clinic. Hematol./Oncol. Clin. North Am. 2:1988;431-436